Mechanisms of pathogenesis: Differences amongst Leishmania species

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 96, Issue SUPPL. 1, 2002, Pages S3-

  Colmenares, Maria ^a   Kar, Sujata ^a   Goldsmith Pestana, Karen ^a   McMahon Pratt, Diane ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Leishmania spp.; Leishmaniasis; Pathogenesis

Indexed keywords

LEISHMANIA VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONTROLLED STUDY; DISEASE SEVERITY; GENETICS; IMMUNE RESPONSE; IMMUNE SYSTEM; INFLAMMATION; LEISHMANIASIS; NONHUMAN; PATHOGENESIS; REVIEW; SKIN LEISHMANIASIS; SPECIES DIFFERENCE; VISCERAL LEISHMANIASIS; ANIMAL; CELLULAR IMMUNITY; CLASSIFICATION; DISEASE MODEL; IMMUNOLOGY; LEISHMANIA; PATHOGENICITY;

ANIMALIA; MURINAE;

ANIMALS; DISEASE MODELS, ANIMAL; IMMUNITY, CELLULAR; LEISHMANIA; LEISHMANIASIS; LEISHMANIASIS, CUTANEOUS;

EID: 85058248882     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0035-9203(02)90044-1     Document Type: Review

References (52)

1. Immune responses associated with susceptibility of C57BL/10 mice to Leishmania amazonensis
2. Serial backcross mapping of multiple loci associated with resistance to Leishmania major infections
3. Genetic control of recovery from visceral leishmaniasis
4. Leishmania donovani infection in heterozygous and recombinant H-2 haplotype mice
5. An H-11 linked gene has a parallel effect on Leishmania major and L. donovani infections in mice
6. Characterization of the immune response in subjects with self-healing cutaneous leishmaniasis
7. Class II major histocompatibility complex-deficient mice initially control an infection with Leishmania major but succumb to the disease
8. Variable expression of the murine natural resistance gene Lsh in different macrophage populations infected in vitro with Leishmania donovani
9. Leishmania-reactive CD4+ and CD8+ T cells associated with cure of human cutaneous leishmaniasis
10. Differences in Lsh gene control over systemic Leishmania major and Leishmania donovani or Leishmania mexicana infections are caused by differential targeting to infiltrating and resident liver macrophage populations
11. Neutralization of IL-12 demonstrates the existence of discrete organ-specific phases in the control of Leishmania donovani
12. Cell populations in the lesions of human cutaneous leishmanasis; a light microscopical, immunohistochemical and ultrastructural study
13. TGF-beta mediates CTLA-4 suppression of cellular immunity in murine kalaazar
14. A transgenic model to analyze the immunoregulatory role of IL-10 secreted by antigen-presenting cells
15. Elimination of CD4+ suppressor T cells from susceptible BALB/c mice releases CD8+ T lymphocytes to mediate protective immunity against Leishmania
16. Differential production of Th1- and Th2-derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis
17. Deficient expression of co-stimulatory molecules on Leishmania-infected macrophages
18. Leishmania-infected macrophages sequester endogenously synthesized parasite antigens from presentation to CD4+ T cells
19. Internalization of Leishmania mexicana complex amastigotes via the Fc receptor is required to sustain infection in murine cutaneous leishmaniasis
20. Anti-TGF-beta treatment promotes rapid healing of Leishmania major infection in mice by enhancing in vivo nitric oxide production
21. The development of effector T cell subsets in murine Leishmania major infection
22. Immunologic determinants of disease evolution in localized cutaneous leishmaniasis due to Leishmania major
23. Cutaneous leishmaniasis. The defect in T cell influx in BALB/c mice
24. Dynamics of granuloma formation in experimental visceral leishmaniasis
25. Recombinant vaccinia viruses expressing GP46/M-2 protect against Leishmania infection
26. Vaccine efficacy of Salmonella strains expressing glycoprotein 63 with different promoters
27. Endogenous interleukin-12 regulates acquired resistance in experimental visceral leishmaniasis
28. Behaviour of visceral Leishmania donovani in an experimentally induced T helper cell 2 (Th2)-associated response model
29. In situ characterization of the human host response to Leishmania panamensis
30. The role of macrophage receptors in adhesion and uptake of Leishmania mexicana amastigotes
31. Presentation of the protective parasite antigen LACK by Leishmania-infected macrophages
32. Pure protein from Leishmania donovani protects mice against both cutaneous and visceral leishmaniasis
33. The regulation of immunity to Leishmania major
34. Resistance to Leishmania major is linked to the H2 region on chromosome 17 and to chromosome 9
35. Mapping of genes conrolling Leishmania major infection in CXS recombinant inbred mice
36. Immunobiological studies on experimental visceral leishmaniasis. I. Changes in lymphoid organs and their possible role in pathogenesis
37. Resistance to macrophage-mediated killing as a factor influencing the pathogenesis of chronic cutaneous leishmaniasis
38. B lymphocytes are required for the generation of T cells that mediate healing of cutaneous leishmaniasis
39. Spectral model of leishmaniasis in congenic strains of mice
40. Host and parasite factors influencing the expression of cutaneous leishmaniasis
41. Destruction of follicular dendritic cells during chronic visceral leishmaniasis
42. B cell deficient mice are highly resistant to Leishmania donovani infection, but develop neutrophil-mediated tissue pathology
43. Leishmania pifanoi amastigote antigens protect mice against cutaneous leishmaniasis
44. Role of CD4+ T cells in pathogenesis associated with Leishmania amazonensis infection
45. Role of L3T4+ and Lyt-2+ cells in experimental visceral leishmaniasis
46. Circulating T helper 1 (Th1) cell- and Th2 cell-associated cytokines in Indian patients with visceral leishmaniasis
47. The role and effect of TNF-α in experimental visceral leishmaniasis
48. Morphology of the spleen and lymph nodes in fatal visceral leishmaniasis
49. The Ity/Lsh/Bcg locus: Natural resistance to infection with intracellular parasites is abrogated by disruption of the Nramp 1 gene
50. Interferon gamma-independent effects of interleukin 12 administered during acute or established infection due to Leishmania major
51. Local suppression of IFN-γ in hepatic granulomas correlates with tissue specific replication of Leishmania chagasi
52. The importance of TGF-beta in murine visceral leishmaniasis